The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•23 February 2026•

1 min read

Surgery Partners Stock Plunges 39% as Irenic Capital Slashes Stake

Key Facts

1Irenic Capital sold 1,047,583 shares of Surgery Partners during the fourth quarter.

2The transaction value was estimated at approximately $19.25 million based on average Q4 pricing.

Surgery Partners (SGRY) shares experienced a massive 39% decline following reports that Irenic Capital significantly reduced its equity stake in the company. During the fourth quarter, the investment fund liquidated approximately 1,047,583 shares of the healthcare services provider. The total value of the transaction was estimated at $19.25 million, based on average pricing throughout the quarter. By the end of the period, the fund's total position value in the company had decreased by $23.19 million due to the combined impact of sales and price fluctuations. This large-scale institutional selling has triggered a sharp sell-off, signaling a potential lack of confidence to the broader market. Investors are now closely monitoring SGRY for signs of stabilization after this substantial institutional exit.